908 Devices Inc Ordinary Shares MASS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue
908 Devices to Participate in the Stifel 2026 Healthcare Conference
908 Devices to Report Third Quarter 2026 Financial Results on November 10, 2026
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
Trading Information
- Previous Close Price
- $9.39
- Day Range
- $9.24–9.86
- 52-Week Range
- $5.03–13.35
- Bid/Ask
- $8.01 / $10.75
- Shares Outstanding
- 41.58M
- Market Cap
- $395.86M
- Volume/Avg
- 3,554 / 401,512
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.49
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 172
- Website
- https://www.908devices.com
Valuation
Metric | MASS |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.63 |
Price/Sales | 5.49 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | MASS |
|---|---|
Quick Ratio | 4.67 |
Current Ratio | 5.43 |
Interest Coverage | — |
Quick Ratio
MASS
Profitability
Metric | MASS |
|---|---|
Return on Assets (Normalized) | −4.13% |
Return on Equity (Normalized) | −5.76% |
Return on Invested Capital (Normalized) | −8.16% |
Return on Assets
MASS
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|q@^x%W< | LOCK|!D$<X | $181B | |||
| Medtronic PLC MDT | LOCK|#n>H>#p | LOCK|#Lx?c | $129B | |||
| Stryker Corp SYK | LOCK|D!dNStrd | LOCK|jk? | $121B | |||
| Boston Scientific Corp BSX | LOCK|d%%S!C | LOCK|^rh^ | $63B | |||
| Edwards Lifesciences Corp EW | LOCK|<$N%@?LV | LOCK|<hw^% | $61B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|#b$B$$v | LOCK|>g | $38B | |||
| DexCom Inc DXCM | LOCK|@T^r@QsX | LOCK|nk#P | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|@L | LOCK|@<z | $29B | |||
| Steris PLC STE | LOCK|?!K<Rwv | LOCK|hVK% | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|z<@&t | LOCK|pn | $20B |